Cosmos Health Inc (COSM) SEC 13F Holdings (Q2 2026): Institutional Buyers & Sellers

COSM ranks #8184 out of 37527 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

COSM is a disclosed holding of Jane Street (Jane Street Group), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

22 institutions disclose a position in COSM, but none treat it as a major bet — even UBS Group AG, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

UBS Group AG has added to its COSM position for two straight quarters, increasing it by $108.2K to reach $110.0K today.

BlackRock has trimmed its COSM position for two straight quarters, cutting it by $83.9K while still holding $49.5K.

COSM reported a net loss of $24.4M over the trailing twelve months.

• Not yet profitable — net loss of $24.4M over the trailing twelve months
• Revenue grew 33.8% year over year
• Net income declined year over year, from -$21.6M to -$24.4M
• Operating cash flow was negative, using $8.4M in cash
• Current ratio of 1.00x — below the conventional 1.5x liquidity buffer
• Liabilities run 1143.34x equity — a highly leveraged balance sheet worth noting